Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension — FDA Drug Shortage
The FDA lists a drug shortage record for Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension (injectable suspension) from Novo Nordisk, Inc. with status No longer listed by FDA. The shortage was first posted on Jul 21, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Novo Nordisk, Inc.
- Package NDC
- 73070-200-11
- Dosage Form
- Injectable Suspension
- Presentation
- Insulin Aspart Protamine and Insulin Aspart Mix 70/30, Injectable Suspension, 10 mL Insulin aspart protamine and insulin aspart Mix 70/30 vial (NDC 73070-200-11)
- Initial Posting
- Jul 21, 2025